ESMO BREAST 2021 - HER2-low breast cancer - what is it anyway?
Watch Now
Q&A with Dr. Melanie Spears on the Characterisation of immune “hot” ER+ breast cancer
Watch Now
ESMO 2021 - HER2-low breast cancer: evolution from primary breast cancer to relapse
Watch Now
Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective
Watch Now
A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)
Watch Now
